Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hong Kong Applied Science and Technology Research Institute (ASTRI) is a government-founded applied research institute based in Hong Kong that develops and commercializes technologies across multiple sectors, including Digital Health and Life Sciences. In healthcare, ASTRI focuses on non-invasive monitoring, early detection, AI-driven diagnostics, telehealth, bioinformatics, medical imaging, and healthcare data analytics rather than therapeutics or traditional drug development. Its health technologies include telehealth platforms, elderly monitoring systems, preventive healthcare systems, capsule endoscopy components, eye health screening devices, and related diagnostic and medical computing solutions. Many of these solutions are developed with commercialization partners and have been adopted by hospitals, care centres, and healthcare service providers. For a biotech analyst, ASTRI is best understood as a cross-disciplinary R&D and technology transfer organization with selective healthcare exposure, not a pure-play biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Kong Applied Science and Technology Research Institute.